McGeorge Anne
- SEC CIK
- 0001779934
In the past year, 1 open-market sale filing worth $844.8K and no purchases.
Current role at each company
- DNTH Dianthus Therapeutics, Inc.Directoras of Aug 11, 2026
- DFPH Starling Oncology, Inc.Directoras of Jul 29, 2026
- TLMD SOC Telemed, Inc.Other: Former Directoras of Apr 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $844.8K
- 1 filing
- Net
- −$844.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists McGeorge Anne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DNTH Dianthus Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 (view filing)5:15 PM ET | Aug 10 | 1 day | McGeorge AnneDirector | SSale | −7.75K | $109.01 | −$844.8K | −100.0%0 after | 5 lots10b5-1 |